Skip to main content
. 2014 Mar 18;143(1):71–80. doi: 10.1017/S0950268814000466

Table 5.

Comparison between sustained virological response (SVR) and response-relapse (RR) in HCV patients with IL-10 genotypes

Genotype SVR (n = 98) RR (n = 30) OR (95% CI) P value Allele frequency
SVR RR
IL-10 AA 47 (48%) 10 (33·5%) 1 (Ref.) 0·71 0·55
 −1082A/G AG 46 (47%) 13 (43·5%) 1·3 (0·53–3·33) 0·54
 (MnII) GG 5 (5%) 7 (23%) 6·6 (1·73–25·01) 0·00* 0·29 0·45
IL-10 CC 36 (37%) 8 (27%) 1 (Ref.) 0·62 0·53
 −819C/T CT 50 (51%) 16 (53%) 1·4 (0·55–3·72) 0·45
 (MaeIII) TT 12 (12%) 6 (20%) 2·2 (0·65–7·80) 0·19 0·38 0·47
IL-10 AA 24 (24·5%) 2 (6·5%) 1 (Ref.) 0·37 0·2
 −592A/C AC 26 (26·5%) 8 (26·5%) 3·7 (0·71–19·14) 0·10
 (RsaI) CC 48 (49%) 20 (67%) 5·0 (1·07–23·18) 0·02* 0·63 0·8

Ref., reference category; OR, odds ratio; CI, confidence interval.

*

P < 0·05 is considered statistically significant.